#LCSM Transcript

Healthcare social media transcript of the #LCSM hashtag.
().
See #LCSM Influencers/Analytics.

Sign up for FREE Symplur Account and Get
  • Create Transcripts with Custom Dates
  • Get Custom Influencer Lists
  • 3x Hashtag Search Results
Sign Up Now
ProfileTweet
Oncocluster @Oncocluster
The latest The Oncology Daily! https://t.co/Evv570nJLB Thanks to @riddler_smitb @Run4Purple @filimasini #lcsm #oncology
Antonio Passaro MD PhD @APassaroMD
@kristi_rosa3 A very not convincing approval by @US_FDA based on immature and very poor efficacy data! This is not precision medicine #LCSM
Christian Rolfo @ChristianRolfo
ok#OncoAlert @EGFRResisters
黒野絵門 Kurono Emon @chroemon
RT @OncLive: BREAKING: @US_FDA Approves Pembrolizumab for Metastatic SCLC #LCSM https://t.co/P7t30U8Ch0
黒野絵門 Kurono Emon @chroemon
RT @kristi_rosa3: The approval is based on pooled results from cohorts of the KEYNOTE-158 & KEYNOTE-028 trials, which showed that the PD-1…
Bonnie Addario @bonnie_addario
Agree. That is the reason we stared our Community LC Centers of Excellence several years ago. To join you need Multi D, genomic profiling full panel and much more. Bringing advanced care to community patients.
SATYAM SINGH @satyamsingh2704
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
SATYAM SINGH @satyamsingh2704
RT @AVIVA1950: Fantastic results, familiar with a case #EGFR targeted therapy Tarceva prolonged life of my peer by 24 months given 3 months…
The Lancet Respiratory Medicine @LancetRespirMed
RT @hilaryarobbins: The benefits & harms of screening for #LungCancer are complex. We developed a new @IARCWHO infographic based on @theNC
Meritxell Ventura @MeritxellVG
RT @theNCI: The Food and Drug Administration has approved pembrolizumab (Keytruda) for some patients with metastatic small cell lung cancer…
OncoAlert @OncoAlert
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
drmanoj @drmanojpgi
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
drmustafabenekli @drbenekli
RT @FDAOncology: FDA granted accelerated approval to pembrolizumab (KEYTRUDA, Merck) for patients with metastatic small cell lung cancer (S…
BreastCancer Chat Ww #BCCWW @bccww
RT @double_whammied: Nice breakdown of an #ASCO19 talk about #SocialMedia / #SoMe and #oncology #bcsm #lcsm #btsm #gyncasm #bccww https://…
Giuseppe Banna @gbanna74
RT @Tony_Calles: 👉 Maybe it is not the steroid use by itself, just a poor-risk factor. Why NSCLC cancer patients treated with immunotherapy…
Giuseppe Banna @gbanna74
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
Andrea Borondy Kitts @findlungcancer
Readministration of Immune Checkpoint Inhibitors After Immune-Related Adverse Events https://t.co/YdknBwG5bo #lcsm #bcsm
Andrea Borondy Kitts @findlungcancer
#publichealth emergency #LCSM #hcldr @CrisAlvaradoMD
Gerald Goh @gerald_goh
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
Gerald Goh @gerald_goh
RT @BrendonStilesMD: This is important. In the basking glow of immunotherapy (from patients, doctors & media), it is tempting to default t…
Drew Moghanaki @DrewMoghanaki
@barttels2 @kennylinafp @lown @AFPJournal @ellakaz @arbmckee @aafp @BrendonStilesMD @findlungcancer @AboutLungCancer @Lung_Screen @LungDocDoug @lung_ca_screen @DrSanjayPopat @CriswellAngela Lots of PCP’s have bought into LCS and are refeeeing people who used to or can’t stop smoking. But, a political machine titled the AAFP is making them feel shameful by spreading misinformation. #lcsm
Daniel Gerlach @gerlach_d
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
metaMartha @Martha__Carlson
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
Brendon Stiles @BrendonStilesMD
RT @DrewMoghanaki: @barttels2 @kennylinafp @lown @AFPJournal @ellakaz @arbmckee @aafp @BrendonStilesMD @findlungcancer @AboutLungCancer @Lu
Guneet Walia @GuneetWalia
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
Guneet Walia @GuneetWalia
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
OncLive.com @OncLive
PACIFIC Study Sets New Standard in Stage III NSCLC, Opens Door to Further Progress @DukeCancer #lcsm https://t.co/C0pCoqtvjW
Vamsi Velcheti, MD @VamsiVelcheti
@LeciaSequist @DrewMoghanaki @kennylinafp @lown @AFPJournal Completely agree with @LeciaSequist #LCSM Lung cancer screen saves lives just like colonoscopies or mammograms. We shouldn’t add more hurdles to screening.
Andrea Borondy Kitts @findlungcancer
#LCSM
Andrea Borondy Kitts @findlungcancer
#LCSM
Andrea Borondy Kitts @findlungcancer
#lcsm
Andrea Borondy Kitts @findlungcancer
#lcsm
Andrea Borondy Kitts @findlungcancer
#lcsm
Andrea Borondy Kitts @findlungcancer
@kennylinafp @LeciaSequist @lown @AFPJournal I’m confused; NLST, NELSON, MILD all showed statistical significance - would you like me to send you the articles? #lcsm
Andrea Borondy Kitts @findlungcancer
#LCSM
Andrea Borondy Kitts @findlungcancer
#lcsm
Lars Medicare @larsmedicares
Check out our latest article on: Measured Volume Set | Information and basic knowledge. https://t.co/tq3frwIqnp #bcsm #MedEd #HCLDR #HITsm #hpm #LCSM #BTSM #hcsmSA #JACR #NephJC #ASEchoJC #SPSM #NurChat #KareoChat #EofL #pharma #SelfCare #homecare #KeepTalkingMH #pharmacy
Jack Lepping @jlepping2013
RT @MLJohnsonMD2: Fierce #LCSM champions gladly making room for courageous #BCSM gladiators @ErikaHamilton9 @VUMC_Cancer Ingrid Mayer at AS…
Sriganesh Srihari @srigsri23
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
Lori Deitte @LoriDeitte
RT @VUMC_Cancer: The dynamic @SandlerRhodes at #strategyshare19 on lung cancer screening strategies that are saving lives #LCSM @VUMCradiol
Celestino Gutiérrez, MD @CelestinoGutirr
RT @EnriqueSoto8: In preparation for the #survivorship debate at #MASCC19 Do you believe all cancer survivors should receive a WRITTEN Surv…
MOC Brasil @MOCBrasil
Imunoterapia aprovada para o tratamento do câncer de pulmão de células pequenas no Brasil A aprovação destina-se à 1L do Ca pulmão pequenas células baseada no fase III IMpower133 #lungcancer #lcsm #immunotherapy @anvisa_oficial Leia a notícia completa: https://t.co/Cy4RM376ko
Becky Haines @grebeccahaines
Check it out @ellakaz @findlungcancer more radiologist engagement
Fernando J. de Miguel @fdemiguelsdp
Exciting! Congrats!
EGFR Resisters @EGFRResisters
Jannie’s Hope Fund for gave @ivybelkins the opportunity to raise awareness about #LungCancer and the need for more research funding on @NCTV17 #lcsm #researchmatters
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @EGFRResisters: Jannie’s Hope Fund for gave @ivybelkins the opportunity to raise awareness about #LungCancer and the need for more resea…
Kim Moran-MacIntosh 🇨🇦 @Kamacintosh
RT @IASLC: We love being able to recognize excellence in #lungcancer care. But to do so, we need your help. The nomination period for the 2…
Kim Moran-MacIntosh 🇨🇦 @Kamacintosh
RT @ivybelkins: Please read the latest newsletter from the @EGFRResisters for a research update from @ASCO, an op-Ed about screening from @…
Kim Moran-MacIntosh 🇨🇦 @Kamacintosh
#lcsm #lungcancer
Kim Moran-MacIntosh 🇨🇦 @Kamacintosh
RT @lgreco_ny: Great, but small waterfall plot for EGFR Drug U3-1402, a HER3 antibody conjugate, which appears to work with all different t…
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @GO2Foundation: Don’t miss our Lung Cancer Living Room, How Lung Cancer is Shaping the Treatment Paradigm for All Cancers, TONIGHT at 5:…
Hunter @realhuntermmm
Referring a patient who is anxious about surgery to a psychologist could potentially improve uptake of life saving cancer treatment
Kim Moran-MacIntosh 🇨🇦 @Kamacintosh
#lcsm #LungCancer
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @lgreco_ny: Great, but small waterfall plot for EGFR Drug U3-1402, a HER3 antibody conjugate, which appears to work with all different t…
Dario Trapani @darioT_
RT @APassaroMD: @kristi_rosa3 A very not convincing approval by @US_FDA based on immature and very poor efficacy data! This is not precisi…
Angela Andersen @LSE_Angela
RT @TGOliver2: Nice. Thanks for posting. I would love for the field to figure out whether immunotherapy differences exist among recently de…
Amy Gravell @amy_gravell
RT @JFreemanDaily: Today @US_FDA granted accelerated approval to pembrolizumab (Keytruda) for patients with metastatic small cell #lungcanc
U-M Rogel Cancer Center @UMRogelCancer
RT @OncLive: Dr. Gadgeel on Updated KEYNOTE-189 Data in NSCLC @UMRogelCancer #lcsm https://t.co/YwVQgYmVP9
son @aiueoeouia123
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
Tatiana Prowell, MD @tmprowell
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
John Stringham @JohnStringham
RT @ABPaulsonNP: So proud to work alongside @SandlerRhodes and witness her bold ideas to save more lives with lung cancer screening. #Strat
MedPage Today @medpagetoday
#Keytruda received a green light from the @US_FDA on Tuesday as a third-line treatment for metastatic small cell #lungcancer. @FDA_Drug_Info #lungcancer #SCLC #LCSM https://t.co/ccK3wBFT0S
Jennifer Wheatley @JenniferWheatle
RT @DeenaRoger: This is why I will be on Capitol Hill on July 23rd. Please join me! Stop #433aday Help #SaveHerLungs #lcsm https://t.co/vxA…
Sarah Morgan @SarahMesoWales
RT @IASLC: Abstract submission for our Latin America Conference on #LungCancer is currently open on our site: https://t.co/r5MdjhfoZZ. The…
BTOG @BTOGORG
Places for the BTOG Lung Cancer Screening Essential Update event in September are booking up fast! FREE for healthcare professionals, book now at https://t.co/VyiobFeyTY #lungcancerscreening #LCSM #lungcancer #thoraciconcology https://t.co/jPorOp17sN
LUNGevityKB @LUNGevityKB
Patient Blog: The Benefit of Early Detection #lungcancer #lcsm https://t.co/oyxkYNhpD3
Tiffany @TiffMGowen
#SaveHerLungs
LabPulse @LabPulse1
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
CancerGeek @CancerGeek
RT @DrewMoghanaki: @barttels2 @kennylinafp @lown @AFPJournal @ellakaz @arbmckee @aafp @BrendonStilesMD @findlungcancer @AboutLungCancer @Lu
Stacey Tinianov @coffeemommy
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
OncologyEducation @OncEd
In this new #Oncology Opinions Series, Dr. Corey Langer presents on the therapeutic landscape in advanced #NSCLC: https://t.co/ciaMc1bAE0 #ImmunoOnc #LCSM https://t.co/AO9nbqW3Qa
Dr. Matthew Schabath @MatthewSchabath
The latest issue of 'Science, Society, and Sports'! https://t.co/BqpOn8CnCm Thanks to @Dav2116 @evltwnHD1 @RoundtownUFO #lcsm #lungcancer
Gil Morgan @weoncologists
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
OncoAlert @OncoAlert
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
Stacey Tinianov @coffeemommy
Wait. WHAT?! Perhaps I'm reading out of context but line "Others, including @AmericanCancer, oppose shared decision-making" definitely caught my eye. And I'm dubious. Really? "Firm Recommendations" & "Shared Decision Making" are NOT mutually exclusive. #lcsm #bcsm #bccww #SDM
OncoAlert @OncoAlert
RT @IASLC: Abstract submission for our Latin America Conference on #LungCancer is currently open on our site: https://t.co/r5MdjhfoZZ. The…
Ria de Grassi @CAFarmersDtr
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
Ria de Grassi @CAFarmersDtr
I remember vividly the 3-mo CT scan routine with my mom. I wish this Lisa here well, with a robust cheering section. #lcsm
JPCRR @JPCRR
RT @Aurora_Cancer: Implementation of a low-dose computerized tomography (LDCT) lung cancer screening program (LCSP) across a large integrat…
Matthias Scheffler @trnsltnl
RT @GO2Foundation: Don’t miss our Lung Cancer Living Room, How Lung Cancer is Shaping the Treatment Paradigm for All Cancers, TONIGHT at 5:…
Jason Broderick @Jasoncology
PACIFIC Study Sets New Standard in Stage III NSCLC, Opens Door to Further Progress https://t.co/sALPBysBdv #lcsm
EGFR Resisters @EGFRResisters
If you haven’t participated in #ProjectPRIORITY yet, it’s not too late! Please click below TODAY to be part of cohort 2 of our EGFR #lungcancer patient-reported survey on lived experiences #lcsm @LUNGevity https://t.co/eglwDrsFuI
Ivy Elkins @ivybelkins
Please join us today! @EGFRResisters @LUNGevity #lcsm #lungcancer #ProjectPRIORITY
Rian M. Hasson Charles, M.D. @DrRianCharles
#Progress
María Isabel Tovar @TovarAris
RT @goecp1: Predictors of Nodal and Metastatic Failure in Early Stage Non–small-cell Lung Cancer After SBRT. Authors built a risk-score mod…
OncLive.com @OncLive
Dr. Nagawaka Discusses Findings of the RELAY Trial in EGFR+ NSCLC #lcsm https://t.co/tg2EYKfMlV
OncLive SOSS @OncLiveSOSS
.@oncoOuLungCA explains how pembrolizumab will be incorporated in the SCLC paradigm following yesterday's @US_FDA approval for patients with metastatic disease #lcsm https://t.co/wIVFq0TL5Q
Antonio Viudez @AntonioViudez
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
Chiara CATANIA @ChiaraCATANIA4
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
Kim Moran-MacIntosh 🇨🇦 @Kamacintosh
Not too late to participate in #ProjectPRIORITY #LCSM #LungCancer
GO2 Foundation for Lung Cancer @GO2Foundation
#WednesdayWisdom | Join us in advocating for the #lungcancer community at the Nat’l Advocacy Summit in Washington, 7/21-23. Your voice will make a difference. Registration closes 6/23, so sign up today! #LCpolicy #LCSM >> https://t.co/AOvusxGGFD https://t.co/w00n83GyND
The ASCO Post @ASCOPost
KEYNOTE-001: 5-Year Overall Survival With Pembrolizumab in Advanced NSCLC https://t.co/JkdkS9dlQ5 #lcsm #oncology #immunotherapy
Kristin Ito @KAdvocate_LCAM
RT @EGFRResisters: If you haven’t participated in #ProjectPRIORITY yet, it’s not too late! Please click below TODAY to be part of cohort 2…
Peter B. Bach, MD @peterbachmd
I do not know the point of AA based on single arm data and an endpoint that is not patient centered when the product already has market approval. I also don’t know the details here but was the pooled analysis pre-specified when dose was different?
Leyla Karaca @LeylaEDelpouve
RT @theNCI: The Food and Drug Administration has approved pembrolizumab (Keytruda) for some patients with metastatic small cell lung cancer…
Oncoinfo_it @Oncoinfo_it
#ASCO19 | A Chicago sono stati presentati dati interessanti nell'ambito del #NSCLC, soprattutto per quanto riguarda la terapia neoadiuvante e la malattia oncogene-addicted. L'overview a firma di Giovanni Mansueto: https://t.co/m4Sc79tvBG #lcsm https://t.co/K5nxR8q7TV
Kimryn Rathmell @KimrynRathmell
How do best impact cancer death rates and simultaneously reduce cost? Prevention and early detection!!! @VUMCHemOnc
OncLive.com @OncLive
Dr. Sands on the Rationale to Explore U3-1401 in EGFR TKI-Resistant EGFR-Mutant NSCLC @DanaFarber #lcsm https://t.co/UaNTZZ1u0t
GYN Cancer | #GYNCSM @gyncsm
RT @NCISymptomMgmt: There are more than 100 types of #Cancer. Types of cancer are usually named for the organs or tissues where the cancers…
Aaron Andersen, MD @adandersen
@itsnot_pink @DrSGraff It’s already deleted. Yeah I agree that is not my definition of a chronic disease either...#lcsm
Matthew Herper @matthewherper
RT @HenryJOncology: Forget #valuebasedcare and pricing, let's go for the #groundshot and with evidence-based approvals. The bar just got ev…
getica @InfoGetica
RT @theNCI: The Food and Drug Administration has approved pembrolizumab (Keytruda) for some patients with metastatic small cell lung cancer…
Bean @Bean65482966
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
Faces of Lung Cancer @LungCancerFaces
@BrendonStilesMD @findlungcancer @kennylinafp @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily Apparently, if anyone disagrees with his negative take on lung screening, even a physician, Kenny Lin blocks. Not a good look. #lcsm
Yusuke Okuma @Y_Okuma_NCCH
RT @StephenVLiu: #OncoAlert Pembrolizumab receives FDA accelerated approval for 3rd line and beyond #SCLC - approval based on KEYNOTE-028 a…
Bob Steele @steele_bob
Yep, this sums it up nicely. Good description of my ADHD-addled brain. Did I hear someone say writer's block. Could of swore I heard it above the music din... #amwriting #writing #lcsm https://t.co/7EdUybq4sw
Bollam Rajesh @BollamRajesh4
RT @kristi_rosa3: The approval is based on pooled results from cohorts of the KEYNOTE-158 & KEYNOTE-028 trials, which showed that the PD-1…
IASLC @IASLC
RT @JTOonline: To accompany today’s Editor’s choice, Dr. Rothschild puts Jeanson and his colleagues findings into greater perspective. The…
Merry-Jennifer Markham @DrMarkham
#lcsm #pallonc
Jean Bustamante-Alvarez MD MS @DoctorJeangoB
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
SCLC Support Group @SCLCSupport
The latest The SCLC Support Community: News Round-Up! https://t.co/v8Zn7aP7sg Thanks to @LungAssociation @sttrcancer @GO2Foundation #lcsm #cancer
IASLC @IASLC
Good morning! Start off your day with a new episode of "Lung Cancer Considered." In this eps, @JackWestMD is joined by Dr. Walter Curran for an extensive discussion on radiation oncology and proton therapy. #LCSM #Oncology #LungCancer Listen in --> https://t.co/tnyC1tdVTH https://t.co/FfZeSH6eIn
H. Jack West, MD @JackWestMD
RT @IASLC: Good morning! Start off your day with a new episode of "Lung Cancer Considered." In this eps, @JackWestMD is joined by Dr. Walte…
Andrea Borondy Kitts @findlungcancer
Immunotherapy NCI Dictionary of Cancer Terms https://t.co/PoxbKxhPe2 #lcsm #bcsm
Laura Book @LauraJBook
RT @EGFRResisters: If you haven’t participated in #ProjectPRIORITY yet, it’s not too late! Please click below TODAY to be part of cohort 2…
Laura Book @LauraJBook
RT @ivybelkins: Please join us today! @EGFRResisters @LUNGevity #lcsm #lungcancer #ProjectPRIORITY https://t.co/nnkCTR5Mi1
JTO @JTOonline
JTO Research Watch: "Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: An Open-Label, Multicenter, Phase III Randomized Trial." #LungCancer #LCSM Read it here: https://t.co/QCKvYdX0oH
Manuel Dómine @ManuelDomine
RT @JFreemanDaily: Today @US_FDA granted accelerated approval to pembrolizumab (Keytruda) for patients with metastatic small cell #lungcanc
Jennifer Ersek @JLErsek
Excited to kickoff the #MyLCI Community Lung Cancer Screening Educator training program with our Respiratory Health partners today!! Thank you to the @LCInitiativeNC for supporting this work! #saveherlungs (and his) #lcsm @KMilehamMD @diamondgrl65 @SSheelaMD https://t.co/a266pl2n5l
OurWarOnCancer @OurWarOnCancer
RT @DeenaRoger: This is why I will be on Capitol Hill on July 23rd. Please join me! Stop #433aday Help #SaveHerLungs #lcsm https://t.co/vxA…
OurWarOnCancer @OurWarOnCancer
RT @ivybelkins: Please join us today! @EGFRResisters @LUNGevity #lcsm #lungcancer #ProjectPRIORITY https://t.co/nnkCTR5Mi1
Jacques Raphael @JackRaph
RT @JTOonline: JTO Research Watch: "Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: An Open-Label, Mult…
OurWarOnCancer @OurWarOnCancer
RT @IASLC: In this piece in the IASLC #LungCancer news, doctors Cornedine Jannette de Gooijer, Maria Disselhorst, and Paul Baas discuss opt…
Alex Friedlaender @DralexGva
How can we fix this insane problem? Standardized tests for all lung adenocarcinoma? Education plays a role too, of course...
CU Cancer Center @CUCancerCenter
Could virtual clinical trials be the thing of the future? A study presented at #ASCO2019 shows that they may be! Full story: https://t.co/ELsnTCvJBz #LCSM @rdoebele https://t.co/aXpRIJ2GIj
Jill Hamer-Wilson 🇨🇦 @JillHW
Thank you, @TO_dpr for introducing @CDNCancerTrials #patientreps to your helpful resources for patient as well as tools for investigators-sponsors-patients #partnerships @OttawaHospital @CAHOhospitals #clinicaltrials #LungCancer #LCSM @CTV_AvisFavaro @ON_FamilyHealth
Bionest Partners @BionestPartners
Merck's Keytruda gives BMS' Opdivo some company with small cell lung cancer nod. Can Keytuda, alongside Opdivo and Tecentriq, shift the treatment paradigm for #SCLC patients? $BMS $MRK #lcsm https://t.co/DwL9uH83sW https://t.co/aQsX3xQlH1
Becky Haines @grebeccahaines
RT @findlungcancer: Immunotherapy NCI Dictionary of Cancer Terms https://t.co/PoxbKxhPe2 #lcsm #bcsm
Christophe Massard @drcmassard
RT @IASLC: Hear presentations from fellow young investigators in training & debates about controversial topics at the IASLC 2019 Mesothelio…
Kyle Ann McKinney @KillianBraun
We did it again! 22 indications and counting!
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @IASLC: Good morning! Start off your day with a new episode of "Lung Cancer Considered." In this eps, @JackWestMD is joined by Dr. Walte…
Oscar Arrieta @ogarrieta
RT @JTOonline: JTO Research Watch: "Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: An Open-Label, Mult…
Oscar Arrieta @ogarrieta
RT @IASLC: Abstract submission for our Latin America Conference on #LungCancer is currently open on our site: https://t.co/r5MdjhfoZZ. The…
UCLA Jonsson Comprehensive Cancer Center @UCLAJCCC
RT @theNCI: The Food and Drug Administration has approved pembrolizumab (Keytruda) for some patients with metastatic small cell lung cancer…
Small Cell Lung Cancer @ES_SCLC
Pembrolizumab (Keytruda) received a green light from the FDA on Tuesday as a third-line treatment for metastatic small cell lung cancer (SCLC), Merck announced. #SmallCellLungCancer #LungCancer #Immunotherapy #LCSM https://t.co/FJ2aIvDxQA
Brendon Stiles @BrendonStilesMD
@kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily Arguments for and against lung cancer screening are very nuanced. I believe BOTH risks and benefits are overestimated. But I also believe that balance of evidence supports screening and that a primary physician should never deny a patient the opportunity to be screened. #lcsm
IASLC @IASLC
Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regular registration prices for the event are available until July 19th. #LCSM Register --> https://t.co/9SzlsHNxVb https://t.co/QslznJCZcQ
Navneet Singh @ns_chd
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
Brendon Stiles @BrendonStilesMD
@kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily I also think that it is a terrible mistake and disservice to eligible patients for @aafp to not recommend lung cancer screening. The article attached https://t.co/MlwNFmA4lm reinforces the negative feelings of many physicians, without doing justice to the benefits. #lcsm
GOECP @goecp1
Survival Outcomes with Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Propensity-Score Matched Analysis of the National Cancer Data Base #radonc #lcsm https://t.co/3jEJUddEKX
BreastCancer Chat Ww #BCCWW @bccww
RT @coffeemommy: Wait. WHAT?! Perhaps I'm reading out of context but line "Others, including @AmericanCancer, oppose shared decision-making…
Mònica Mercadé Pons @mercade_monica
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
TREC @TRECResearch
Thanks @JimMann83105425 for alerting us to this. Very interesting!
METUP @METUPorg
#Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these trials NOW. Washouts need to be based on the individual patient. One washout does NOT fit all. #bcsm #metastasticBC #lcsm https://t.co/gtft2Fu6Ez
AASC @AASC2
RT @IASLC: Abstract submission for our Latin America Conference on #LungCancer is currently open on our site: https://t.co/r5MdjhfoZZ. The…
Umberto Malapelle @UmbertoMalapel1
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @OncLive: Dr. Nagawaka Discusses Findings of the RELAY Trial in EGFR+ NSCLC #lcsm https://t.co/tg2EYKfMlV
OurWarOnCancer @OurWarOnCancer
RT @IASLC: Good morning! Start off your day with a new episode of "Lung Cancer Considered." In this eps, @JackWestMD is joined by Dr. Walte…
Faces of Lung Cancer @LungCancerFaces
RT @ivybelkins: Please join us today! @EGFRResisters @LUNGevity #lcsm #lungcancer #ProjectPRIORITY https://t.co/nnkCTR5Mi1
T. Allen Pannell, Jr @T_Allen1998
That is a very confusing comment. If I take it literally, I have to call BS. I don't know of any case where shared decision making is not warranted, but in screening it is a must. There are smart good people on both sides of screening, so obviously it is a close call.
Pramesh CS @cspramesh
Another example of the @US_FDA lowering an already low bar in drug approvals.
Liz O'Riordan @Liz_ORiordan
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @ivybelkins: Please join us today! @EGFRResisters @LUNGevity #lcsm #lungcancer #ProjectPRIORITY https://t.co/nnkCTR5Mi1
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @EGFRResisters: If you haven’t participated in #ProjectPRIORITY yet, it’s not too late! Please click below TODAY to be part of cohort 2…
Benjamin King, MD @BenjaminKingMD1
RT @lcsmchat: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” with mod…
Robin Holmes @Majormac1
Just saw where a #metastasticBC pt had scary amount of progression during 4 wk washout period. #clinicaltrials should not intentionally make pts worse. Her drug shelf life was two weeks. #bcsm #lcsm #malebreastcancer
Pasquale Pisapia @PasqualePisapia
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
Andrea Borondy Kitts @findlungcancer
RT @BrendonStilesMD: @kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily Ar…
Andrea Borondy Kitts @findlungcancer
RT @BrendonStilesMD: @kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily I…
Lisa Moran @plh4lisa
Words I heard at today's results appointment for my 3 month follow up scan and labs: Easy, normal and boring! That means a great report! #lcsm #stage4 #lungcancer #reamplh4lisa https://t.co/ksBScEZYFP
Targeted Oncology @TargetedOnc
Two abstracts presented at #ASCO19 analyzed potential combinations with osimertinib, a third-generation EGFR TKI, with additional agents to potentially overcome resistance mutations following progression in patients with EGFR-mutant NSCLC. https://t.co/Gil3LmGTay #lcsm #nsclc
Kathleen D. Hoffman @drkdhoffman
The #LCSM Twitter chat took up the debate on Right To Try...What is Right To Try? What is Compassionate Use/Expanded Access? Do we really need new legislation? Read more here! https://t.co/gqrPjsudSK https://t.co/FWZo85wsnp
Kit D @Diamondtrees11
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Bollam Rajesh @BollamRajesh4
RT @JFreemanDaily: Today @US_FDA granted accelerated approval to pembrolizumab (Keytruda) for patients with metastatic small cell #lungcanc
Chad Rusthoven @cgr0105
RT @IASLC: Join us on 6/25 at 2 p.m. as we host a live webinar featuring esteemed speakers @cgr0105 and @samsonpp as they discuss, "How to…
joey steward @jsteward2930
RT @TargetedOnc: Two abstracts presented at #ASCO19 analyzed potential combinations with osimertinib, a third-generation EGFR TKI, with add…
Liz Szabo @LizSzabo
RT @drkdhoffman: The #LCSM Twitter chat took up the debate on Right To Try...What is Right To Try? What is Compassionate Use/Expanded Acces…
Lung Cancer Project @LungProject
Thank you for participating! The answer is 50% - approximately half of lung cancers are covered by known genetic biomarkers. Learn more about the scientific advancements made in lung cancer that have helped make new treatment options available. https://t.co/hUOTGW7tgs #lcsm
Liz Highleyman @LizCancerHealth
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Cancer Health @cancerhealthmag
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Christian Flores @Christi37310517
RT @JTOonline: JTO Research Watch: "Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: An Open-Label, Mult…
Susan Rahn @Stickit2Stage4
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Susan Rahn @Stickit2Stage4
RT @Majormac1: Just saw where a #metastasticBC pt had scary amount of progression during 4 wk washout period. #clinicaltrials should not in…
Eon @eonhealth
PLEASE tell us why #healthcare stakeholders are choosing to implement software that has failed #healthtech so much that parody accounts exist for their failures?! Workflow, clinical value & #patientcare DON'T have to be neglected to increase ROI! #lcsm #hcIT #medtwitter #meded https://t.co/5q7JcF1OYB
Tim Kruser @TimothyKruserMD
RT @BrendonStilesMD: @kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily Ar…
Alicia C. Staley @stales
RT @coffeemommy: Wait. WHAT?! Perhaps I'm reading out of context but line "Others, including @AmericanCancer, oppose shared decision-making…
metaMartha @Martha__Carlson
RT @Majormac1: Just saw where a #metastasticBC pt had scary amount of progression during 4 wk washout period. #clinicaltrials should not in…
GOECP @goecp1
Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer. #radonc #LCSM https://t.co/s0OiNsysK3 https://t.co/qUzYlEWyk1
🎀 Vicki Grant @queenvickig
RT @Merck: We are pleased to share our latest #lungcancer news: https://t.co/0eBeZHN2zG $MRK #LCSM https://t.co/SJSr5zE3sK
Molecular Pathology UK @molpathuk
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
Double Whammy @double_whammied
Hey thanks for the name check @chadinabhan @marklewismd -- and the great essay on the importance of #cancer #patient voices! #ASCO2019 #bcsm #lcsm #btsm #hcsm #gyncasm https://t.co/BAM6CLblc4
Faces of Lung Cancer @LungCancerFaces
RT @BrendonStilesMD: @kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily Ar…
chadi nabhan MD, MBA @chadinabhan
RT @double_whammied: Hey thanks for the name check @chadinabhan @marklewismd -- and the great essay on the importance of #cancer #patient v…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily I…
#LCSM Chat @lcsmchat
RT @BrendonStilesMD: @kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily Ar…
Núria Rodg de Dios @nuria_dios
RT @goecp1: Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer. #radonc #LCSM https://t.co/s0…
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
@lori_burwell I got that a lot when I was first diagnosed... #LCSM
Vivek Subbiah, MD @VivekSubbiah
Make NGS part of diagnosis for #NSCLC @n8pennell & @PatelOncology ! An example for Diagnosis should be BRAF V600e mutant, PDL1 negative, NTRK fusion negative, TMB high, MSI-H non-small cell lung cancer @StephenVLiu @VamsiVelcheti @bensolomon1 @LeciaSequist
Mike Thompson, MD, PhD, FASCO @mtmdphd
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
Vivek Subbiah, MD @VivekSubbiah
Make NGS part of diagnosis for #NSCLC @n8pennell & @PatelOncology ! An example for Diagnosis should be BRAF V600e mutant, PDL1 negative, NTRK fusion negative, TMB high, MSI-H non-small cell lung cancer @StephenVLiu @VamsiVelcheti @bensolomon1 @LeciaSequist @ChristianRolfo #LCSM
feedkast Medical @feedkastMedical
New video in our #lungcancer feed 'Dr. Ou on Investigational KRAS Inhibitors in Lung Cancer' from @OncLive https://t.co/VkqCSg3rlp #nsclc #lcsm Have a look in the feed for more curated content from top sources! https://t.co/z8u8Tfkyz9
Mike Thompson, MD, PhD, FASCO @mtmdphd
Overall most active new tags were those organized Twitter-based chats: #ayacsm #gyncsm #lcsm #mmsm & #pancsm https://t.co/MvRkLR8FP4 #ASCO15
Christophe Massard @drcmassard
RT @BrendonStilesMD: This is important. In the basking glow of immunotherapy (from patients, doctors & media), it is tempting to default t…
Dr Riyaz Shah @DrRiyazShah
Great talk at East Midlands Lung Cancer Expert Forum 2019 from Prof Samreen Ahmed on 1 st line ALKi options. #LCSM https://t.co/BeDbjadcSQ
Autodidact @iamukasa
RT @eonhealth: PLEASE tell us why #healthcare stakeholders are choosing to implement software that has failed #healthtech so much that paro…
Juan Luis Cruz @jotaelecruz
Thrilled for presenting our research in #WCLC19 @IASLC. Grateful to the jury for accepting new approaches in lung cancer management based on #datascience #analytics #bigdata #rwd #endoflifecare #PhD @MARIANOPROVENCI @ernesmena @CTBUPM @La_UPM https://t.co/IsPtgqMoXD
Dr Riyaz Shah @DrRiyazShah
East Midlands Lung Cancer Expert Forum 2019. Delighted that Sandra Wakelin was able to share the Maidstone nurse led IO assessment pathway. The future for @NHSEngland #LCSM @MTWnhs https://t.co/kX13FBikuv
LungCancerInitiative @LCInitiativeNC
RT @Merck: We are pleased to share our latest #lungcancer news: https://t.co/0eBeZHN2zG $MRK #LCSM https://t.co/SJSr5zE3sK
Stephen V Liu @StephenVLiu
RT @VivekSubbiah: Make NGS part of diagnosis for #NSCLC @n8pennell & @PatelOncology ! An example for Diagnosis should be BRAF V600e mutant,…
LungCancerInitiative @LCInitiativeNC
Exciting news from @merck on this breakthrough. FDA approves Keytruda for metastatic small cell lung cancer. #nclungcancer #lungcancerawareness
M.Provencio @MARIANOPROVENCI
RT @jotaelecruz: Thrilled for presenting our research in #WCLC19 @IASLC. Grateful to the jury for accepting new approaches in lung cancer m…
Virginia M. Byrne @VirginiaMByrne
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Joaquín J Cabrera @JoaquinJCabrera
RT @goecp1: Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer. #radonc #LCSM https://t.co/s0…
Andrea Borondy Kitts @findlungcancer
#LCSM
Joaquín J Cabrera @JoaquinJCabrera
RT @goecp1: Survival Outcomes with Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Propensity-Score Matched Analysis of…
Sebastian Defranchi @sdefranchi
@BrendonStilesMD @kennylinafp @LungCancerFaces @findlungcancer @lown @AFPJournal @aafp @AmericanCancer @DrewMoghanaki @JFreemanDaily I think there’s enough evidence in favor of screening. Risks exist, but can be minimized with proper recommendations from a dedicated team. Waiting for the full text Nelson trial, which presented last year @WCLC and showed even more benefit than NLST #lcsm
Cristobal Alvarado @CrisAlvaradoMD
RT @findlungcancer: #LCSM https://t.co/ppWcNSm7Wr
Dave Bjork @bjork5
Sending positive vibes your way @plh4lisa —> #lcsm #lungcancer #teamplh4lisa
Pablo Munoz Schuffenegger @pablomunozsch
Last few days for @IASLC members to vote! Please join me in voting for @DrBezjakRO for the Board of Directors. An amazing leader and advocate for the #LungCancer #lcsm #Radonc community! https://t.co/KxjWifLbIk
aHoi @aHoi56406301
RT @ivybelkins: Please join us today! @EGFRResisters @LUNGevity #lcsm #lungcancer #ProjectPRIORITY https://t.co/nnkCTR5Mi1
Meredith Giuliani @MeredithGiulia1
RT @pablomunozsch: Last few days for @IASLC members to vote! Please join me in voting for @DrBezjakRO for the Board of Directors. An amazin…
Fabio Y. Moraes, MD, PhD(c) @Fymoraes
RT @pablomunozsch: Last few days for @IASLC members to vote! Please join me in voting for @DrBezjakRO for the Board of Directors. An amazin…
Virginia M. Byrne @VirginiaMByrne
Washout periods are a huge area of concern for #metastatic patients in the Lung Cancer & Lung Cancer mutations community. #lcsm #hcsm @alk_fusion @ALKLungCancer @EGFRResisters @Poyyoypi
Targeted Oncology @TargetedOnc
Dr. Spigel gave us a recap on the phase III PACIFIC study, with facts and perceptions surrounding the latest data that study researchers reported during #ASCO19. https://t.co/yJ1vrrMxUD #LungCancer #lcsm
Edison A. Carrasco @Kroquemort2
RT @TargetedOnc: Dr. Spigel gave us a recap on the phase III PACIFIC study, with facts and perceptions surrounding the latest data that stu…
Virginia M. Byrne @VirginiaMByrne
@CancerCareMASCC Glad you are interested in including real folks living with cancer in your seminar re cancer survivorship! You are expected to pick up their expenses, give them an honoraria & treat them like honored guests. #lcsm #bcsm #hcsm @alk_fusion @ALKLungCancer
The ASCO Post @ASCOPost
Radiotherapy Increases Adverse Cardiovascular Event Risk for Patients With Lung Cancer https://t.co/2QOhKD35bD #lcsm #oncology #radonc
Virginia M. Byrne @VirginiaMByrne
RT @ivybelkins: Please join us today! @EGFRResisters @LUNGevity #lcsm #lungcancer #ProjectPRIORITY https://t.co/nnkCTR5Mi1
Stephen V Liu @StephenVLiu
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
Lesley Stephen @LesleycStephen
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Virginia M. Byrne @VirginiaMByrne
A friend with breast cancer now has lung cancer, both treated @sloan_kettering, asks me: where are patient committees, why no nurse navigators? Same hospital, second-class experience. #StigmaStings #lcsm #bcsm @BrendonStilesMD @NarjustDumaMD @ShereefElnahal @GO2Foundation
Felipe Couñago PhD @fcounago
RT @goecp1: Survival Outcomes with Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Propensity-Score Matched Analysis of…
Santiago Viteri @DrViteri
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
Sophie @misssophiebot
RT @eonhealth: PLEASE tell us why #healthcare stakeholders are choosing to implement software that has failed #healthtech so much that paro…
IASLC @IASLC
Targeted Oncology presents an article highlighting the findings from two studies that show positive results from neoadjuvant #immunotherapy in #NSCLC." #LCSM Read it here: https://t.co/nLAmG0PRNr
Aki Alzubaidi @aki_alzubaidi
RT @eonhealth: PLEASE tell us why #healthcare stakeholders are choosing to implement software that has failed #healthtech so much that paro…
Dr Riyaz Shah @DrRiyazShah
Great talk from @dean_fennell on IO acquired resistance mechanisms and targetable checkpoints. Immune editing and microbiome particularly fascinated me #LCSM https://t.co/tUcUbl23Cl
Lisa Astor @oncolisa
RT @TargetedOnc: The FDA approved pembrolizumab for the treatment of patients with metastatic small cell lung cancer who have disease progr…
Christophe Massard @drcmassard
RT @VivekSubbiah: Make NGS part of diagnosis for #NSCLC @n8pennell & @PatelOncology ! An example for Diagnosis should be BRAF V600e mutant,…
Anna Maria Morelli @AnnaMar80406088
RT @IASLC: Targeted Oncology presents an article highlighting the findings from two studies that show positive results from neoadjuvant #im
Giannis Mountzios @gmountzios
RT @HenningWillers: So thrilled! Finally out in @CellReports: #EGFR targeted therapy induces #PARP inhibitor sensitivity in EGFR mutant #lu
Verónica Varas @veronicavarasm
RT @jotaelecruz: Thrilled for presenting our research in #WCLC19 @IASLC. Grateful to the jury for accepting new approaches in lung cancer m…
Andres F. Cardona @AndresFCardonaZ
Congrats great data
Andres F. Cardona @AndresFCardonaZ
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
Andres F. Cardona @AndresFCardonaZ
RT @IASLC: Targeted Oncology presents an article highlighting the findings from two studies that show positive results from neoadjuvant #im
Andrea Borondy Kitts @findlungcancer
@VPrasadMDMPH @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @BrendonStilesMD @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist De Konin H, et al. on behalf controlled population-based screening trial. WCLC 2018; Abstract PLo2.05.of NELSON investigators. Effects of volume CT lung cancer screening. Mortality results of the NELSON randomized, controlled population based screening trial #lcsm
Andrea Borondy Kitts @findlungcancer
@VPrasadMDMPH @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @BrendonStilesMD @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist suspect publishing journal has embargoed release until they publish. This is usually standard practice - all of us are anxious to see the full journal article - having been in the audience @iaslc #wclc18 in Toronto & knowing the players I'm pretty sure it won't disappoint. #lcsm
Eon @eonhealth
Data organization is overwhelming and time consuming. Most navigators are STILL USING BINDERS 😱 Locate, track & diagnose MORE #patients; Reduce fatigue & increase downstream to drs. Simple right? #SoMeDocs #NurseTwitter #lcsm #radonc #pccm #hcldr #hscm https://t.co/FEpsTkpS01 https://t.co/TFYG0MYnQI
David McDougle @davidmcdougle
RT @TestLungCancer: PGA golf champion Jason Day’s mom taught him to never give up. Find out why they are encouraging other people facing #l
Andrea Borondy Kitts @findlungcancer
@CrisAlvaradoMD @VPrasadMDMPH @SethBKrantz @DrewMoghanaki @kennylinafp @BrendonStilesMD @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist Folks - this is key - reduced #lungcancer mortality has already been shown with LDCT screening, thousands of lives have been lost as many wait for NELSON - a confirmatory study - #lcsm
Ben Solomon @bensolomon1
RT @VivekSubbiah: Make NGS part of diagnosis for #NSCLC @n8pennell & @PatelOncology ! An example for Diagnosis should be BRAF V600e mutant,…
Andrea Borondy Kitts @findlungcancer
@VPrasadMDMPH @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @BrendonStilesMD @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist I agree patients should know the results - however, there are other ways to share results with patients not just publishing in a peer reviewed journal. In fact, results should be shared with patients throughout the trial & not just at the end #lcsm #pfcc
Lou War @TumorWarrior
The latest Brain Tumor Awareness! https://t.co/W26d5uNRYH Thanks to @double_whammied @NIHBrainTumor @larsmedicares #btsm #lcsm
CCS Associates, Inc. @ccsainc
RT @theNCI: The Food and Drug Administration has approved pembrolizumab (Keytruda) for some patients with metastatic small cell lung cancer…
Laronica Conway @louisianagirl91
Listen, it's been seven years for me since mom died from #lungcancer and I'm JUST NOW, in 2019, feeling somewhat back to myself. My compass was broken. Anyway, making sure the #LCSM family sees this! cc: @DANIELJAMESREC
Tara Herrmann, PhD @TaraHerrmannPhD
This. Individuals at high risk need to be screened for lung cancer #lcsm
Cristobal Alvarado @CrisAlvaradoMD
RT @findlungcancer: @CrisAlvaradoMD @VPrasadMDMPH @SethBKrantz @DrewMoghanaki @kennylinafp @BrendonStilesMD @lown @AFPJournal @ShannonBrown
Daniel J Kerley 🏃‍♂️✈️☕️🇺🇸🐶 @DANIELJAMESREC
RT @louisianagirl91: Listen, it's been seven years for me since mom died from #lungcancer and I'm JUST NOW, in 2019, feeling somewhat back…
OncLive.com @OncLive
Quest Continues to Turn NSCLC Into Chronic Disease #lcsm https://t.co/cryUJdavoJ
Seth Krantz, MD @SethBKrantz
RT @findlungcancer: @CrisAlvaradoMD @VPrasadMDMPH @SethBKrantz @DrewMoghanaki @kennylinafp @BrendonStilesMD @lown @AFPJournal @ShannonBrown
Radiation Medicine Program @RadMedPM
RT @pablomunozsch: Last few days for @IASLC members to vote! Please join me in voting for @DrBezjakRO for the Board of Directors. An amazin…
Andres F. Cardona @AndresFCardonaZ
RT @IASLC: Good morning! Start off your day with a new episode of "Lung Cancer Considered." In this eps, @JackWestMD is joined by Dr. Walte…
Ian Weissman, DO @DrIanWeissman
RT @findlungcancer: #publichealth emergency #LCSM #hcldr @CrisAlvaradoMD https://t.co/eInlOQuEMQ
Matthias Scheffler @trnsltnl
Thanks @weoncologists @OncoAlert @cclc2019 @GlobalOncoEdu for the productive coop! #LCSM
anxious procrastinator @Carrera13
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
Spannerinmyworks @SpannerInMe
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
RT @EGFRResisters: If you haven’t participated in #ProjectPRIORITY yet, it’s not too late! Please click below TODAY to be part of cohort 2…
Andrea Borondy Kitts @findlungcancer
@BrendonStilesMD @VPrasadMDMPH @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist @bmj_latest Yes please explain that for us #LCSM
Jenn Sharp @Jenn_Quilts
RT @METUPorg: We light 116 candles for those lost to #metastasticBC today. More research hands on deck are needed to unlock a complicated d…
Andrea Borondy Kitts @findlungcancer
@LeciaSequist @VPrasadMDMPH @BrendonStilesMD @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO MILD also showed 20% all cause mortality benefit with continuous screening at 10 years of follow-up #lcsm
Andrea Borondy Kitts @findlungcancer
@VPrasadMDMPH @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @BrendonStilesMD @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist @bmj_latest the "control" arm was CRX because the PLCO trial was evaluating CRX vs no screening and it was believed that CRX might be the new standard of care - turned out not to be the case #lcsm
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
#LCSM
Ivy Smith @IVfromNowhere
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
Andrea Borondy Kitts @findlungcancer
@VPrasadMDMPH @BrendonStilesMD @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist @bmj_latest need to find lung cancer early for cure; NLST = 20% reduction #lungcancer mortality MILD = 20% all cause mortality - @LaheyHospital we are screening with Gr8 metrics published in peer reviewed journals & saving lives #lcsm https://t.co/2YuveDPxgv
Andrea Borondy Kitts @findlungcancer
@VPrasadMDMPH @BrendonStilesMD @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist @bmj_latest @LaheyHospital ps journal article has lots of tables and data for you to read and review #lcsm
Andrea Borondy Kitts @findlungcancer
@VPrasadMDMPH @BrendonStilesMD @CrisAlvaradoMD @SethBKrantz @DrewMoghanaki @kennylinafp @lown @AFPJournal @ShannonBrownlee @JeanneLenzer1 @chrisdraft @Pattybeatslungc @biniamkidaneMD @chrisslatore @PercyLeeMD @jillfeldman4 @JillHW @Kamacintosh @ivybelkins @aesfCEO @LeciaSequist @bmj_latest @LaheyHospital my favorite quote "Those who say it can't be done should not bother those that are doing it" #lcsm
可知健太 @kachikenta
かなり遅ればせながら、exon20変異陽性に対するtak-788です。ORR45パーセント程度。非小細胞肺がんは、まだまだ有望な薬剤がアーリーフェーズで沢山ありすごい。
黒野絵門 Kurono Emon @chroemon
RT @Tony_Calles: EGFR exon 20 mutations: an urgent medical need. TAK-788 efficacy and safety. Small numbers but it’s way better than histo…
可知健太 @kachikenta
記事をオンコロにのせましたが、ウォーターフォールは示せないのでこちら、乳がんよりも奏効率やや落ちる?印象ですが、タグリッソフェイラーの次の薬剤として期待ですね。 https://t.co/nny26srkHq
OurWarOnCancer @OurWarOnCancer
RT @VirginiaMByrne: Washout periods are a huge area of concern for #metastatic patients in the Lung Cancer & Lung Cancer mutations communit…
OurWarOnCancer @OurWarOnCancer
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
OurWarOnCancer @OurWarOnCancer
RT @IASLC: Targeted Oncology presents an article highlighting the findings from two studies that show positive results from neoadjuvant #im
OurWarOnCancer @OurWarOnCancer
RT @VirginiaMByrne: A friend with breast cancer now has lung cancer, both treated @sloan_kettering, asks me: where are patient committees,…
Faces of Lung Cancer @LungCancerFaces
Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” with moderator @BrendonStilesMD. Read more here: https://t.co/7qfcM3EGF2… LCSM=Lung Cancer Social Media. Join the conversation! #StayAlive https://t.co/Q1rIHAICfF
Micki Huston @BrstCanSrvMicki
RT @stage4kelly: And the same thing has been found with breast cancer. Bottom line: metastatic cancer isn’t your fault. It’s not because yo…
National Cancer Institute @theNCI
What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat #lungcancer: https://t.co/xGwpHtLE5K #LCSM https://t.co/1UXnkT34ad
Pub Health Monitor @monitor_PH
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
OurWarOnCancer @OurWarOnCancer
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
Chris @OneChrisCurry
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
#LCSM Chat @lcsmchat
Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” with moderator @BrendonStilesMD. Read more here: https://t.co/uYpIPLjm5W… LCSM=Lung Cancer Social Media. Join the conversation! #hcsm https://t.co/181gbVAwnJ
Sherry DeVries @sherrydevries
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Inspire @teaminspire
RT @lcsmchat: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” with mod…
caregiver... @stevecripe57
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
Vamsi Velcheti, MD @VamsiVelcheti
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
Ranjeet Kumar @strategicpolicy
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
HAKan @HakanKucuksayan
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Kim Moran-MacIntosh 🇨🇦 @Kamacintosh
RT @lcsmchat: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” with mod…
Roxanne Phillips @Foxyroxierox
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Manda @twittmanda
RT @TargetedOnc: Two abstracts presented at #ASCO19 analyzed potential combinations with osimertinib, a third-generation EGFR TKI, with add…
toge @intnaidaa
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Dr. Matthew Schabath @MatthewSchabath
The latest issue of 'Science, Society, and Sports'! https://t.co/3gngH3pp7n Thanks to @BrendonStilesMD @LiberalTalknPts @OICR_news #lcsm #cancer
Carolina @Caroga1497
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Babyf8ce @Shalisa_Renee
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Dr. David Tom Cooke @DavidCookeMD
RT @lcsmchat: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” with mod…
Lung Cancer Halflung @LungCancerHalfL
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
Lung Cancer Halflung @LungCancerHalfL
#lcsm @CDMRP #lcrp
Deb Smith 🦋🌻🦉🐢🌿 @debsmithbeach
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
TranslationalGenomic @TGEGatONJCRI
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
Bob Steele @steele_bob
RT @LungCancerFaces: Join us for #LCSM Chat this Thursday 6/20/19 at 5pm Pacific, 8pm Eastern: “Recent Lung Cancer Conference Highlights” w…
Laura Book @LauraJBook
RT @VirginiaMByrne: Washout periods are a huge area of concern for #metastatic patients in the Lung Cancer & Lung Cancer mutations communit…
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @IASLC: Targeted Oncology presents an article highlighting the findings from two studies that show positive results from neoadjuvant #im
Katsuaki Maehara Ph.D @KatsuakiMaehara
RT @ASCOPost: Radiotherapy Increases Adverse Cardiovascular Event Risk for Patients With Lung Cancer https://t.co/2QOhKD35bD #lcsm #oncolog
J.Creed @creeden35
RT @TestLungCancer: PGA golf champion Jason Day’s mom taught him to never give up. Find out why they are encouraging other people facing #l
G Gamble @gpg3
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Danielle Karber @danielle_dk
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
Adela @adelapoite
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
CU Cancer Center @CUCancerCenter
Study: Virtual clinical trial gives entrectinib edge over crizotinib against ROS1+ non-small cell lung cancer https://t.co/ELsnTCvJBz #ASCO2019 #lcsm #lungcancer https://t.co/KZkgXxQdnE
Adela @adelapoite
RT @goecp1: Survival Outcomes with Thoracic Radiotherapy in Extensive-Stage Small Cell Lung Cancer: A Propensity-Score Matched Analysis of…
joey steward @jsteward2930
RT @CUCancerCenter: Study: Virtual clinical trial gives entrectinib edge over crizotinib against ROS1+ non-small cell lung cancer https://t…
Adela @adelapoite
RT @JTOonline: JTO Research Watch: "Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: An Open-Label, Mult…
Brendon Stiles @BrendonStilesMD
@JeanneLenzer1 2) This seems important: Are you saying that out of 26,309 patients screened for lung cancer with CT scans, there were 27,034 major complications resulting from those CT scans? Seems like a public health emergency. #lcsm
Brendon Stiles @BrendonStilesMD
@JeanneLenzer1 4) If what you say is true, should the @NEJM paper be retracted? #lcsm
Dwana Calhoun, MS @DeeCalhounSMHN
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Deb @deb9455
RT @TestLungCancer: PGA golf champion Jason Day’s mom taught him to never give up. Find out why they are encouraging other people facing #l
Dr. Arturo Loaiza-Bonilla @DrBonillaOnc
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
NCI Clinical & Molecular Pharmacology Figg Labs @NCICCRPharmLab
RT @theNCI: What's happening in lung cancer research? Here's an update on some of the latest findings on how to prevent, detect, and treat…
Leisa D. Lackey @diamondgrl65
RT @JLErsek: Excited to kickoff the #MyLCI Community Lung Cancer Screening Educator training program with our Respiratory Health partners t…
OncLive SOSS @OncLiveSOSS
Scott J. Antonia, MD, PhD, of @DukeCancer, discusses the pivotal data that renewed interest in stage III unresectable NSCLC and anticipates data that are expected to advance the field even further. #lcsm https://t.co/iXjkeqe4Sx
Faces of Lung Cancer @LungCancerFaces
RT @METUPorg: #Metastatic patients don't have the luxury of time necessary for washout periods required by #clinicaltrials. They need these…
SeqComplete @SeqComplete
The SeqComplete Daily&Nightly is out! https://t.co/Xpnmqc2EkS #lungcancer #lcsm
Eden Lake @EdenLake
Our Ally in #congress rick.nolan Speaking at the lifeandbreathrally April 2018. #CongressmanRickNolan #LCSM #WorldLungCancerDay #LifeAndBreathRally2018 #WashingtonDC #EndTheStigma #AllYouNeedAreLungshttps://t.co/kzc73KdqiT
Bellvitge_Asma @Bellvitge_asma
RT @hilaryarobbins: The benefits & harms of screening for #LungCancer are complex. We developed a new @IARCWHO infographic based on @theNC
filippo masini @filimasini
RT @JTOonline: JTO Research Watch: "Prophylactic Irradiation of Tracts in Patients with Malignant Pleural Mesothelioma: An Open-Label, Mult…
Elad Sharon @EladSharonMD
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
filippo masini @filimasini
RT @n8pennell: This is an emergency and must be addressed. Reports from academic centers that routinely test for molecular targets have giv…
Sandra Ortiz-Cuaran @SandraOrtizCua
Although I really wanted to, I cannot make it for #CCLC19 😑. I'm very glad to read about this cooperation for livestreming the talks. Great initiative! #LCSM @EGFRResisters @ALKLungCancer @ros1cancer
CancerWallonia @CancerWallonia
RT @OncLiveSOSS: Scott J. Antonia, MD, PhD, of @DukeCancer, discusses the pivotal data that renewed interest in stage III unresectable NSCL…
Dr Nazrina @dr_nazrina
RT @DrRiyazShah: East Midlands Lung Cancer Expert Forum 2019. Delighted that Sandra Wakelin was able to share the Maidstone nurse led IO as…
CU Cancer Center @CUCancerCenter
Study: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors. Full story: https://t.co/Tw7IhIcWoj #LCSM ASCO2019 #lungcancer https://t.co/0krwP21puC
joey steward @jsteward2930
RT @CUCancerCenter: Study: 40-50 percent response rate for brigatinib after other next-gen ALK inhibitors. Full story: https://t.co/Tw7IhIc…
Israel Rodriguez A @israelo430
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
Scott Kirkelie @SKirkelie
RT @TestLungCancer: PGA golf champion Jason Day’s mom taught him to never give up. Find out why they are encouraging other people facing #l
Bermes Project @bermesproject
RT @IASLC: Join us this September in beautiful Barcelona, Spain, as we host the IASLC 2019 World Conference on Lung Cancer (#WCLC19). Regul…
Pasquale Pisapia @PasqualePisapia
RT @OncLive: Dr. Sands on the Rationale to Explore U3-1401 in EGFR TKI-Resistant EGFR-Mutant NSCLC @DanaFarber #lcsm https://t.co/UaNTZZ1u0t
#LCSM content from Twitter.